COVID-19, ECMO, and lymphopenia: a word of caution
暂无分享,去创建一个
[1] Qiurong Ruan,et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.
[2] Ting Yu,et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.
[3] Jie-shou Li,et al. Continuous renal replacement therapy reduces the systemic and pulmonary inflammation induced by venovenous extracorporeal membrane oxygenation in a porcine model. , 2014, Artificial organs.
[4] D. Kaufman,et al. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults* , 2011, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[5] T. Ueland,et al. Interleukin-6 may predict survival in extracorporeal membrane oxygenation treatment , 2008, Perfusion.